Influence of the Implantation Site on the Sensitivity of Patient Pancreatic Tumor Xenografts to Apo2L/Trail Therapy

Pancreas - United States
doi 10.1097/mpa.0000000000000099
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Patient-Derived Breast Tumor Xenografts Facilitating Personalized Cancer Therapy

Breast Cancer Research
Cancer ResearchOncology
2013English

Noninvasive Molecular Imaging Sheds Light on the Synergy Between 5-Fluorouracil and TRAIL/Apo2L for Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2007English

Enhanced Tumor Killing by Apo2L/Trail and CPT-11 Co-Treatment Is Associated With P21 Cleavage and Differential Regulation of Apo2L/Trail Ligand and Its Receptors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Implantation Site-Dependent Dysfunction of Transplanted Pancreatic Islets

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Influence of Pacing Site Characteristics on Response to Cardiac Resynchronization Therapy

Circulation. Cardiovascular imaging
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2013English

Paving the TRAIL to Anti-Fibrotic Therapy

Hepatology
MedicineHepatology
2016English

The Influence of a Human Embryonic Stem Cell–Derived Microenvironment on Targeting of Human Solid Tumor Xenografts

Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy